$CGNX
COGNEX CORP

2023 Q2 Form 10-Q Financial Statement

#000085120523000008 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $201.1M $282.4M
YoY Change -28.78% 18.15%
Cost Of Revenue $57.38M $78.79M
YoY Change -27.17% 45.79%
Gross Profit $143.7M $203.6M
YoY Change -29.41% 10.07%
Gross Profit Margin 71.47% 72.1%
Selling, General & Admin $83.04M $80.84M
YoY Change 2.72% 11.61%
% of Gross Profit 57.77% 39.7%
Research & Development $38.54M $36.05M
YoY Change 6.9% 5.71%
% of Gross Profit 26.81% 17.71%
Depreciation & Amortization $3.986M $4.117M
YoY Change -3.18% -3.33%
% of Gross Profit 2.77% 2.02%
Operating Expenses $121.6M $116.9M
YoY Change 4.01% 9.73%
Operating Profit $22.16M $86.73M
YoY Change -74.45% 10.55%
Interest Expense $3.981M $1.024M
YoY Change 288.77% 104.8%
% of Operating Profit 17.96% 1.18%
Other Income/Expense, Net $73.00K -$48.00K
YoY Change -252.08% -71.43%
Pretax Income $26.22M $87.70M
YoY Change -70.11% 11.26%
Income Tax $600.0K $20.37M
% Of Pretax Income 2.29% 23.23%
Net Earnings $25.62M $67.33M
YoY Change -61.96% -3.6%
Net Earnings / Revenue 12.74% 23.84%
Basic Earnings Per Share $0.15 $0.39
Diluted Earnings Per Share $0.15 $0.38
COMMON SHARES
Basic Shares Outstanding 172.6M shares 174.1M shares
Diluted Shares Outstanding 173.9M shares 176.7M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $380.9M $314.7M
YoY Change 21.01% -18.45%
Cash & Equivalents $164.2M $165.8M
Short-Term Investments $216.7M $149.0M
Other Short-Term Assets $63.08M $61.63M
YoY Change 2.34% 36.06%
Inventory $127.1M $136.7M
Prepaid Expenses
Receivables $144.2M $155.1M
Other Receivables $4.559M $2.940M
Total Short-Term Assets $722.2M $672.9M
YoY Change 7.32% 7.56%
LONG-TERM ASSETS
Property, Plant & Equipment $81.27M $77.87M
YoY Change 4.37% 1.02%
Goodwill $242.0M $241.2M
YoY Change 0.36% -0.76%
Intangibles
YoY Change
Long-Term Investments $463.0M $479.4M
YoY Change -3.42% -2.24%
Other Assets $6.725M $7.158M
YoY Change -6.05% -6.94%
Total Long-Term Assets $1.252B $1.261B
YoY Change -0.74% -1.73%
TOTAL ASSETS
Total Short-Term Assets $722.2M $672.9M
Total Long-Term Assets $1.252B $1.261B
Total Assets $1.974B $1.934B
YoY Change 2.07% 1.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.94M $44.73M
YoY Change -39.78% 113.32%
Accrued Expenses $83.53M $63.12M
YoY Change 32.33% 4.47%
Deferred Revenue $57.81M $54.46M
YoY Change 6.15% 5.41%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $214.0M $195.1M
YoY Change 9.66% 22.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $444.0K $15.22M
YoY Change -97.08% 60.96%
Total Long-Term Liabilities $444.0K $15.22M
YoY Change -97.08% 60.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $214.0M $195.1M
Total Long-Term Liabilities $444.0K $15.22M
Total Liabilities $527.7M $575.4M
YoY Change -8.28% 4.24%
SHAREHOLDERS EQUITY
Retained Earnings $517.5M $488.5M
YoY Change 5.94% -9.65%
Common Stock $992.7M $933.5M
YoY Change 6.35% 9.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.446B $1.359B
YoY Change
Total Liabilities & Shareholders Equity $1.974B $1.934B
YoY Change 2.07% 1.32%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $25.62M $67.33M
YoY Change -61.96% -3.6%
Depreciation, Depletion And Amortization $3.986M $4.117M
YoY Change -3.18% -3.33%
Cash From Operating Activities $27.55M $49.52M
YoY Change -44.36% -49.8%
INVESTING ACTIVITIES
Capital Expenditures $5.507M $4.585M
YoY Change 20.11% 88.22%
Acquisitions $0.00
YoY Change
Other Investing Activities -$281.0K $73.82M
YoY Change -100.38% -153.34%
Cash From Investing Activities -$5.788M $69.24M
YoY Change -108.36% -149.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $24.18M $130.4M
YoY Change -81.46% 1912.73%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$39.32M -$138.1M
YoY Change -71.53% -881.63%
NET CHANGE
Cash From Operating Activities $27.55M $49.52M
Cash From Investing Activities -$5.788M $69.24M
Cash From Financing Activities -$39.32M -$138.1M
Net Change In Cash -$17.20M -$20.39M
YoY Change -15.64% -22.71%
FREE CASH FLOW
Cash From Operating Activities $27.55M $49.52M
Capital Expenditures $5.507M $4.585M
Free Cash Flow $22.05M $44.93M
YoY Change -50.93% -53.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000851205
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
001-34218
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
COGNEX CORP
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2713778
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
One Vision Drive
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Natick
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01760
CY2023Q2 dei City Area Code
CityAreaCode
508
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
650-3000
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock, par value $.002 per share
CY2023Q2 dei Trading Symbol
TradingSymbol
CGNX
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-02
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
172601360 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
201124000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
282407000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
57384000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
78790000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
143740000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
203617000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38542000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36054000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
83037000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80835000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22161000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
86728000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
394000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-444000 usd
CY2023Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3587000 usd
CY2022Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1468000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
73000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-48000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26215000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87704000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20371000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25615000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
67333000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172624000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174146000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173903000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176668000 shares
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.070
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.065
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25615000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
67333000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1858000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-4036000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13548000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-36000 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
5426000 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-13512000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-359000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2111000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-359000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2111000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5067000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-15623000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30682000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
51710000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164171000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181374000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
220943000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
223545000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent
0 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
216703000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
218759000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1001000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
730000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
144154000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
125417000 usd
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2354000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2179000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
127147000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
122480000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67634000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67490000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
722163000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
717699000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
407241000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
478329000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
476148000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Noncurrent
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Noncurrent
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent
0 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
463039000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
454117000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81274000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
79714000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37769000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37682000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
242041000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
242630000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11472000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12414000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
409583000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6725000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6643000 usd
CY2023Q2 us-gaap Assets
Assets
1974066000 usd
CY2022Q4 us-gaap Assets
Assets
1958140000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
26939000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27103000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
83527000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
93235000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
37529000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
18129000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
57805000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40787000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8177000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8454000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
213977000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
187708000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31389000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31298000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
243557000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
249961000 usd
CY2023Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
20030000 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
15866000 usd
CY2023Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
18338000 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
33008000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
444000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1905000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
527735000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
519746000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2023Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
345000 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2022Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
172601000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
172601000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
172631000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
172631000 shares
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
345000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
992690000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
979167000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
517526000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
528179000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64230000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69297000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1446331000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1438394000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1974066000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1958140000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25615000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
67333000 usd
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
16579000 usd
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
15056000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
3986000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
4117000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
942000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
840000 usd
CY2023Q2 cgnx Excess And Obsolete Inventory Charges
ExcessAndObsoleteInventoryCharges
788000 usd
CY2022Q2 cgnx Excess And Obsolete Inventory Charges
ExcessAndObsoleteInventoryCharges
379000 usd
CY2023Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-700000 usd
CY2022Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1402000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-36000 usd
CY2023Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
10656000 usd
CY2022Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3891000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18455000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24700000 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-173000 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2144000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5338000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23900000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-231000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4212000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-192000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
708000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9942000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-28718000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
4721000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
16745000 usd
CY2023Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
17003000 usd
CY2022Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
18712000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1744000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
958000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27553000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49517000 usd
CY2023Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
46480000 usd
CY2022Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
39155000 usd
CY2023Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
46199000 usd
CY2022Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
112976000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5507000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4585000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5788000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
69236000 usd
CY2023Q2 cgnx Proceeds Payments Issuance Of Shares Share Based Payment Arrangement Including Option Exercised Net
ProceedsPaymentsIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercisedNet
-3055000 usd
CY2022Q2 cgnx Proceeds Payments Issuance Of Shares Share Based Payment Arrangement Including Option Exercised Net
ProceedsPaymentsIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercisedNet
3594000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
24178000 usd
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
130405000 usd
CY2023Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12091000 usd
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11303000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-39324000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-138114000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1031000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17203000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20392000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
181374000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186161000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164171000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165769000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1438394000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-3055000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24178000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16579000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.070
CY2023Q2 us-gaap Dividends Cash
DividendsCash
12091000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25615000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1858000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5426000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-359000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1446331000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1430093000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3594000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
130405000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15056000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.065
CY2022Q2 us-gaap Dividends Cash
DividendsCash
11303000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
67333000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-4036000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13548000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-36000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2111000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1358745000 usd
CY2022Q4 us-gaap Cash
Cash
180959000 usd
CY2023Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
3618000 usd
CY2023Q2 us-gaap Cash
Cash
160553000 usd
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
415000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164171000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181374000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
216703000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
218759000 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
463039000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
454117000 usd
CY2023Q2 cgnx Cash Cash Equivalents Short Term And Long Term Investments
CashCashEquivalentsShortTermAndLongTermInvestments
843913000 usd
CY2022Q4 cgnx Cash Cash Equivalents Short Term And Long Term Investments
CashCashEquivalentsShortTermAndLongTermInvestments
854250000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
699272000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2232000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
21762000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
679742000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
98436000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1434000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
409469000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
20328000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
507905000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
21762000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
118000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
154000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
216703000 usd
CY2023Q2 cgnx Available For Sale Securities Debt Maturities After One Year Before Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneYearBeforeTwoYearsFairValue
173141000 usd
CY2023Q2 cgnx Available For Sale Securities Debt Maturities After Two Years Before Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTwoYearsBeforeThreeYearsFairValue
116078000 usd
CY2023Q2 cgnx Available For Sale Securities Debt Maturities After Three Years Before Four Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsBeforeFourYearsFairValue
88781000 usd
CY2023Q2 cgnx Available For Sale Securities Debt Maturities After Four Years Before Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsBeforeFiveYearsFairValue
82812000 usd
CY2023Q2 cgnx Available For Sale Securities Debt Maturities After Five Years
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYears
2227000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
679742000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
77520000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
71720000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1489000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
906000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
48138000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
49854000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
127147000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
122480000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2392000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2229000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2404000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2079000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
24000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
38000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7284000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7530000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5477000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4221000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3716000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3448000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
12769000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
44445000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
39566000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
39752000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.033
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.033
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M18D
CY2022Q4 us-gaap Goodwill
Goodwill
242630000 usd
CY2023Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-589000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
242041000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34195000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22723000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11472000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34195000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21781000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12414000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
74000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4375000 usd
CY2023Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
527000 usd
CY2023Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
828000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4074000 usd
CY2023Q2 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
47486000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
154000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
27000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
74000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
479000 usd
CY2023Q2 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
0 usd
CY2022Q4 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
0 usd
CY2023Q2 us-gaap Derivative Liability Collateral Right To Reclaim Cash Offset
DerivativeLiabilityCollateralRightToReclaimCashOffset
0 usd
CY2022Q4 us-gaap Derivative Liability Collateral Right To Reclaim Cash Offset
DerivativeLiabilityCollateralRightToReclaimCashOffset
0 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
154000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
27000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
479000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
201124000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
282407000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
201124000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
282407000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Gross
CapitalizedContractCostGross
20219000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Gross
CapitalizedContractCostGross
14578000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
730000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
350000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
78000 usd
CY2023Q2 cgnx Accounts Receivable Allowance For Credit Loss Foreign Exchange Rate Adjustment
AccountsReceivableAllowanceForCreditLossForeignExchangeRateAdjustment
-1000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1001000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
40787000 usd
CY2023Q2 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
34786000 usd
CY2023Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
8578000 usd
CY2023Q2 us-gaap Deferred Revenue Refund Payments1
DeferredRevenueRefundPayments1
9205000 usd
CY2023Q2 cgnx Deferred Revenue Foreign Currency Exchange Adjustment
DeferredRevenueForeignCurrencyExchangeAdjustment
15000 usd
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
57805000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8467000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
51.56
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1228000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
47.21
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
140000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
28.36
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
247000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
58.05
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9308000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
51.16
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M10D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
37312000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5433000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
47.45
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M13D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
22.45
CY2023Q2 cgnx Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue
33531000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
8735000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
50.90
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y4M13D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
36643000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.040
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0059
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0040
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.39
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.37
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M18D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.79
CY2023Q2 cgnx Shares Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Intrinsic Value
SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableIntrinsicValue
3439000 usd
CY2022Q2 cgnx Shares Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Intrinsic Value
SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableIntrinsicValue
2615000 usd
CY2023Q2 cgnx Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue
31181000 usd
CY2022Q2 cgnx Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue
25535000 usd
CY2023Q2 cgnx Number Of Groups Within Employee Population
NumberOfGroupsWithinEmployeePopulation
3 group
CY2023Q2 cgnx Estimated Forfeiture Rate For Unvested Options For Ceo
EstimatedForfeitureRateForUnvestedOptionsForCEO
0
CY2023Q2 cgnx Estimated Forfeiture Rate For Unvested Options For Senior Management
EstimatedForfeitureRateForUnvestedOptionsForSeniorManagement
0.08
CY2023Q2 cgnx Estimated Forfeiture Rate For Unvested Options For All Non Senior Management
EstimatedForfeitureRateForUnvestedOptionsForAllNonSeniorManagement
0.13
CY2023Q2 cgnx Decrease In Compensation Expense Due To Revised Estimated Forfeiture Rates
DecreaseInCompensationExpenseDueToRevisedEstimatedForfeitureRates
234000 usd
CY2022Q2 cgnx Increase In Compensation Expense Due To Revised Estimated Forfeiture Rates
IncreaseInCompensationExpenseDueToRevisedEstimatedForfeitureRates
1536000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
86841000 usd
CY2023Q2 cgnx Employee Service Sharebased Compensation Nonvested Awards Compensation Notyet Recognized Periodfor Recognition
EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotyetRecognizedPeriodforRecognition
P2Y4M24D
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16579000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2308000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15056000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2319000 usd
CY2022Q4 cgnx Employee Service Share Based Compensation Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationRecognizedPeriodCostsCapitalizedAmount
0 usd
CY2023Q2 cgnx Employee Service Share Based Compensation Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationRecognizedPeriodCostsCapitalizedAmount
0 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16579000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15056000 usd
CY2023Q2 cgnx Taxyearsopentoexaminationby Internal Revenue Service
TaxyearsopentoexaminationbyInternalRevenueService
2019 through 2022
CY2023Q2 cgnx Income Tax Examination Years Under Examination Other Entities
IncomeTaxExaminationYearsUnderExaminationOtherEntities
2017 through 2022
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.02
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23
CY2023Q2 cgnx Effective Income Tax Rate Reconciliation Discrete Tax Expense Benefit Amount
EffectiveIncomeTaxRateReconciliationDiscreteTaxExpenseBenefitAmount
-3594000 usd
CY2022Q2 cgnx Effective Income Tax Rate Reconciliation Discrete Tax Expense Benefit Amount
EffectiveIncomeTaxRateReconciliationDiscreteTaxExpenseBenefitAmount
-6338000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1068000 usd
CY2022Q4 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
2292000 usd
CY2022Q4 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2198000 usd
CY2023Q2 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
172000 usd
CY2022Q2 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
1417000 usd
CY2022Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1734000 usd
CY2022Q2 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3187000 usd
CY2022Q2 cgnx Effective Income Tax Rate Reconciliation Excluding Discrete Items Percent
EffectiveIncomeTaxRateReconciliationExcludingDiscreteItemsPercent
0.16
CY2023Q2 cgnx Effective Income Tax Rate Reconciliation Excluding Discrete Items Percent
EffectiveIncomeTaxRateReconciliationExcludingDiscreteItemsPercent
0.16
CY2023Q2 cgnx Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
20030000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172624000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174146000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1279000 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2522000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173903000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176668000 shares
CY2022 cgnx Gross Loss From Catastrophes
GrossLossFromCatastrophes
48339000 usd
CY2022Q4 us-gaap Insurance Recoveries
InsuranceRecoveries
27560000 usd

Files In Submission

Name View Source Status
0000851205-23-000008-index-headers.html Edgar Link pending
0000851205-23-000008-index.html Edgar Link pending
0000851205-23-000008.txt Edgar Link pending
0000851205-23-000008-xbrl.zip Edgar Link pending
a422023-10qxexhibit311.htm Edgar Link pending
a422023-10qxexhibit312.htm Edgar Link pending
a422023-10qxexhibit321.htm Edgar Link pending
a422023-10qxexhibit322.htm Edgar Link pending
cgnx-20230402.htm Edgar Link pending
cgnx-20230402.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
cgnx-20230402_def.xml Edgar Link unprocessable
cgnx-20230402_cal.xml Edgar Link unprocessable
cgnx-20230402_lab.xml Edgar Link unprocessable
cgnx-20230402_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cgnx-20230402_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending